Waheed N. Khan

1.1k total citations
32 papers, 902 citations indexed

About

Waheed N. Khan is a scholar working on Epidemiology, Microbiology and Pharmacology. According to data from OpenAlex, Waheed N. Khan has authored 32 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Microbiology and 7 papers in Pharmacology. Recurrent topics in Waheed N. Khan's work include Bacterial Infections and Vaccines (19 papers), Pneumonia and Respiratory Infections (18 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Waheed N. Khan is often cited by papers focused on Bacterial Infections and Vaccines (19 papers), Pneumonia and Respiratory Infections (18 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Waheed N. Khan collaborates with scholars based in United States, Saudi Arabia and Pakistan. Waheed N. Khan's co-authors include William J. Rodríguez, Richard H. Schwartz, Sydney Ross, Jesús M Feris, Gabriel J. Hauser, Raafat S. Hannallah, Frank M. Midgley, William Casey, William J. Rodriguez and John W. Boslego and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Waheed N. Khan

30 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waheed N. Khan United States 16 472 451 191 188 97 32 902
Carla Odio Costa Rica 18 647 1.4× 448 1.0× 206 1.1× 107 0.6× 340 3.5× 32 1.5k
J Wedgwood Switzerland 12 361 0.8× 267 0.6× 201 1.1× 156 0.8× 72 0.7× 13 766
A Marton Hungary 7 489 1.0× 217 0.5× 128 0.7× 125 0.7× 110 1.1× 17 619
Nabil I. Girgis Egypt 11 429 0.9× 390 0.9× 62 0.3× 62 0.3× 121 1.2× 25 831
William E. Feldman United States 12 345 0.7× 336 0.7× 140 0.7× 95 0.5× 123 1.3× 28 665
W M Gooch United States 21 462 1.0× 69 0.2× 190 1.0× 61 0.3× 292 3.0× 65 1.2k
Herbert S. Heineman United States 13 235 0.5× 187 0.4× 34 0.2× 41 0.2× 99 1.0× 23 640
M. Boucherat France 23 747 1.6× 337 0.7× 85 0.4× 35 0.2× 301 3.1× 75 1.5k
Daniel Ivler United States 16 572 1.2× 300 0.7× 133 0.7× 106 0.6× 88 0.9× 34 1.1k
Sheila Hickey United States 12 478 1.0× 353 0.8× 172 0.9× 79 0.4× 136 1.4× 16 709

Countries citing papers authored by Waheed N. Khan

Since Specialization
Citations

This map shows the geographic impact of Waheed N. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waheed N. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waheed N. Khan more than expected).

Fields of papers citing papers by Waheed N. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waheed N. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waheed N. Khan. The network helps show where Waheed N. Khan may publish in the future.

Co-authorship network of co-authors of Waheed N. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Waheed N. Khan. A scholar is included among the top collaborators of Waheed N. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waheed N. Khan. Waheed N. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khan, Waheed N., et al.. (2014). Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus. 30(7). 1 indexed citations
3.
Odio, Carla, Jesús M Feris, Waheed N. Khan, et al.. (1999). Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. The Pediatric Infectious Disease Journal. 18(7). 581–590. 62 indexed citations
4.
Rodriguez, William J., et al.. (1995). Streptococcus pneumoniae resistant to penicillin: Incidence and potential therapeutic options. The Laryngoscope. 105(3). 300–304. 11 indexed citations
5.
Shyu, Wen Chyi, et al.. (1994). Penetration of cefprozil into middle ear fluid of patients with otitis media. Antimicrobial Agents and Chemotherapy. 38(9). 2210–2212. 22 indexed citations
6.
Casey, William, Gabriel J. Hauser, Raafat S. Hannallah, Frank M. Midgley, & Waheed N. Khan. (1992). Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Critical Care Medicine. 20(8). 1090–1096. 95 indexed citations
7.
Schwartz, Richard H., et al.. (1991). PENICILLIN AND TRIMETHOPRIM-SULFAMETHOXAZOLE-RESISTANT PNEUMOCOCCI ISOLATED FROM BLOOD CULTURES OF THREE INFANTS IN METROPOLITAN WASHINGTON, DC. The Pediatric Infectious Disease Journal. 10(10). 782–782. 7 indexed citations
8.
Feris, Jesús M, et al.. (1989). Aztreonam in the Treatment of Gram-Negative Meningitis and Other Gram-Negative Infections. Chemotherapy. 35(1). 31–38. 4 indexed citations
9.
Boslego, John W., et al.. (1987). Effect of Spectinomycin Use on the Prevalence of Spectinomycin-Resistant and of Penicillinase-ProducingNeisseria Gonorrhoeae. New England Journal of Medicine. 317(5). 272–278. 110 indexed citations
10.
Rodríguez, William J., et al.. (1983). Erythromycin-sulfisoxazole for persistent acute otitis media due to ampicillin-resistant Haemophilus influenzae. The Pediatric Infectious Disease Journal. 2(1). 27–29. 8 indexed citations
11.
Schwartz, Richard H., William Rodriguez, Waheed N. Khan, Lori E. Brigham, & Sydney Ross. (1982). Evaluation of Cefaclor in Acute Otitis Media Caused by Ampicillin-resistant H. influenzae. Clinical Pediatrics. 21(7). 402–404.
12.
Schwartz, R H, et al.. (1982). Trimethoprim-Sulfamethoxazole in the Treatment of Otitis Media Caused by Ampicillin-Resistant Strains of Haemophilus influenzae. Clinical Infectious Diseases. 4(2). 514–516. 11 indexed citations
13.
Schwartz, Richard H., William J. Rodriguez, & Waheed N. Khan. (1981). Persistent Purulent Otitis Media. Clinical Pediatrics. 20(7). 445–447. 15 indexed citations
14.
Schwartz, Richard H., et al.. (1980). Trimethoprim-Sulfamethoxazole in the Treatment of Otitis Media Secondary to Ampicillin-Resistant Strains of Haemophilus Influenzae. Annals of Otology Rhinology & Laryngology. 89(3_suppl). 281–284. 11 indexed citations
15.
Schwartz, Richard H., William J. Rodríguez, Ronald D. Mann, Waheed N. Khan, & Sydney Ross. (1979). The nasopharyngeal culture in acute otitis media. A reappraisal of its usefulness.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 241(20). 2170–3. 56 indexed citations
16.
Rodriguez, William, Harry B. Greenberg, Waheed N. Khan, et al.. (1978). 810 HUMAN ROTAVIRUS (HRV) AND HEAT LABILE ENTEROTOXIN (LT) DETECTION IN A PEDIATRIC POPULATION. Pediatric Research. 12. 498–498. 3 indexed citations
17.
Controni, Guido, et al.. (1977). Cerebrospinal fluid lactic acid levels in meningitis. The Journal of Pediatrics. 91(3). 379–384. 56 indexed citations
18.
Controni, Guido, et al.. (1974). OTITIS MEDIA DUE TO AMPICILLIN-RESISTANT HÆMOPHILUS INFLUENZÆ. The Lancet. 304(7893). 1398–1398. 9 indexed citations
19.
Khan, Waheed N.. (1974). Haemophilus influenzae type B resistant to ampicillin. A report of two cases. JAMA. 229(3). 298–301. 29 indexed citations
20.
Khan, Waheed N., et al.. (1969). Immunoglobulin M determinations in neonates and infants as an adjunct to the diagnosis of infection. The Journal of Pediatrics. 75(6). 1282–1286. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026